MNKD | Mannkind corporation - Stock Value & PE Ratio Analysis

3

24

15

Average Growth

AI analysis rates MNKD with a medium value score of 3.
It is mainly due to stable revenue growth, but with concerns regarding unstable operating cash flow.
Over the past 3 months, MNKD has maintained a consecutive value rating of 3.0, slightly higher than the rating of 2.5 over the past 3 years, indicating higher growth opportunities for enterprise value.
Compared to all stocks in the Health Care sector, MNKD has a medium value rating.

MNKD Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

Update to 2025/03/02 (Weekly Update)

MNKD Financial Forecast

Unit : USD

Update to 2025/5/4 (Quarterly Update)

MNKD Earnings Table

Unit : USD

QTR	Non-GAAP EPS	EPS YoY	EPS Surprise %	Sales	Sales YoY	Sales Surprise %	NPM
Current	0.03	50%	0%	76.78M	31.3%	2.4%	16.5%
2024Q2	0.04	100%	-33.3%	70.08M	36.7%	-6.4%	-2.8%
2024Q1	0.05	350%	-249.9%	72.39M	48.9%	11.7%	16%
2023Q4	0.04	200%	53.8%	66.26M	63.1%	9.5%	2.4%
2023Q3	0.02	128.6%	-300%	58.47M	62.2%	9.1%	3.4%

Update to 2025/5/7 (Quarterly Update)

MNKD Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

MNKD Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry

Exit

The Backtest Result of MNKD from 2007/01 till Now

196.75%
Cumulative Return: 6.12%
Annual Return: 30.91%
Volatility: 0.20
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from January, 2007 to May, 2025. (Total Trades: 1)